These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26076125)

  • 1. Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads.
    Verfuerth S; Sousa PS; Beloki L; Murray M; Peters MD; O'Neill AT; Mackinnon S; Lowdell MW; Chakraverty R; Samuel ER
    Bone Marrow Transplant; 2015 Oct; 50(10):1358-64. PubMed ID: 26076125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.
    Teschner D; Distler E; Wehler D; Frey M; Marandiuc D; Langeveld K; Theobald M; Thomas S; Herr W
    Bone Marrow Transplant; 2014 Jan; 49(1):138-44. PubMed ID: 23933765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
    Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
    Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy.
    Mangare C; Tischer-Zimmermann S; Bonifacius A; Riese SB; Dragon AC; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Transfus Med Hemother; 2022 Feb; 49(1):30-43. PubMed ID: 35221866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.
    Mangare C; Tischer-Zimmermann S; Riese SB; Dragon AC; Prinz I; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
    Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI).
    Smetak M; Kimmel B; Birkmann J; Schaefer-Eckart K; Einsele H; Wilhelm M; Kunzmann V
    Bone Marrow Transplant; 2008 Apr; 41(7):643-50. PubMed ID: 18037935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
    Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.
    Foster AE; Marangolo M; Sartor MM; Alexander SI; Hu M; Bradstock KF; Gottlieb DJ
    Blood; 2004 Oct; 104(8):2403-9. PubMed ID: 15231569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
    J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Innovative Standard Operation Procedure for Isolating GMP-Grade CD4
    Zhang W; Watt SM; Roberts DJ
    Methods Mol Biol; 2019; 1899():67-83. PubMed ID: 30649766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation.
    Tittlbach H; Schneider A; Strobel J; Zimmermann R; Maas S; Gebhardt B; Rauser G; Mach M; Mackensen A; Winkler TH; Winkler J
    J Transl Med; 2017 Nov; 15(1):228. PubMed ID: 29115976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
    Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector function-deficient memory CD8+ T cells clonally expand in the liver and give rise to peripheral memory CD8+ T cells.
    Su YC; Lee CC; Kung JT
    J Immunol; 2010 Dec; 185(12):7498-506. PubMed ID: 21078905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation.
    Klyuchnikov E; Sputtek A; Slesarchuk O; Lioznov M; Stübig T; Bacher U; Amtsfeld G; Merle E; Reckhaus ML; Fehse B; Wolschke C; Adjallé R; Ayuk F; Zander A; Kröger N
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):374-83. PubMed ID: 20637880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of central memory CD8 T cells is independent of CD62L-mediated trafficking to lymph nodes.
    Wirth TC; Badovinac VP; Zhao L; Dailey MO; Harty JT
    J Immunol; 2009 May; 182(10):6195-206. PubMed ID: 19414773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.
    Tischer S; Kaireit T; Figueiredo C; Hiller O; Maecker-Kolhoff B; Geyeregger R; Immenschuh S; Blasczyk R; Eiz-Vesper B
    Int Immunol; 2012 Sep; 24(9):561-72. PubMed ID: 22740564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-reactive CD8+ memory stem cells in graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    Nat Med; 2005 Dec; 11(12):1299-305. PubMed ID: 16288282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.